Effective January 1, 2025, Blue Shield of California will no longer cover drugs for weight loss, unless medically necessary for the treatment of Class III obesity.
Coverage for COVID-19 testing (including at-home test kits) and therapeutics will be subject to the member’s deductible in accordance with the updated IRS requirements for HSA compatible HDHPs effecti...
A new biosimilar for Humira, the world’s best-selling drug, will be available at $0 co-pay for most members starting 1/1/2025 with the launch of Blue Shield’s Pharmacy Care Reimagined model for commer...
Blue Shield of California will be implementing an update to the outpatient pharmacy benefit for Large Group regarding member cost shares for brand drugs with generic equivalents available.
Three DPPO plans will be withdrawn from Blue Shield's Specialty portfolio beginning January 1, 2025. See mapping grid for the list of withdrawn plans and corresponding recommended available plans.